Syngene International Dirección
Dirección controles de criterios 3/4
El CEO de Syngene International's es Jonathan Hunt , nombrado en Jan 2016, tiene una permanencia de 8.25 años. compensación anual total es ₹84.75M, compuesta por 100% salario y 0% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.088% de las acciones de la empresa, por valor de ₹243.47M. La antigüedad media del equipo directivo y de la junta directiva es de 7.2 años y 6.8 años, respectivamente.
Información clave
Jonathan Hunt
Chief Executive Officer (CEO)
₹84.8m
Compensación total
Porcentaje del salario del CEO | 100.0% |
Permanencia del CEO | 8.3yrs |
Participación del CEO | 0.09% |
Permanencia media de la dirección | 7.3yrs |
Promedio de permanencia en la Junta Directiva | 6.8yrs |
Actualizaciones recientes de la dirección
Recent updates
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Mar 28Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?
Feb 14Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)
Jan 19Is Syngene International (NSE:SYNGENE) A Risky Investment?
Nov 19Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?
Nov 01Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly
Aug 07These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Apr 28Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching
Apr 06Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Jan 04Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet
Dec 08Is Syngene International (NSE:SYNGENE) Using Too Much Debt?
Aug 28Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 10These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well
May 10Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?
Feb 02Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Nov 26Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly
Sep 21Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock
Aug 06The CEO Of Syngene International Limited (NSE:SYNGENE) Might See A Pay Rise On The Horizon
Jul 14Is Syngene International (NSE:SYNGENE) A Risky Investment?
Jun 09We Think Syngene International (NSE:SYNGENE) Can Stay On Top Of Its Debt
Feb 18Syngene International Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jan 23Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2024 | n/a | n/a | ₹5b |
Dec 31 2023 | n/a | n/a | ₹5b |
Sep 30 2023 | n/a | n/a | ₹5b |
Jun 30 2023 | n/a | n/a | ₹5b |
Mar 31 2023 | ₹85m | ₹85m | ₹5b |
Dec 31 2022 | n/a | n/a | ₹4b |
Sep 30 2022 | n/a | n/a | ₹4b |
Jun 30 2022 | n/a | n/a | ₹4b |
Mar 31 2022 | ₹76m | ₹76m | ₹4b |
Dec 31 2021 | n/a | n/a | ₹4b |
Sep 30 2021 | n/a | n/a | ₹4b |
Jun 30 2021 | n/a | n/a | ₹4b |
Mar 31 2021 | ₹65m | ₹65m | ₹4b |
Dec 31 2020 | n/a | n/a | ₹4b |
Sep 30 2020 | n/a | n/a | ₹4b |
Jun 30 2020 | n/a | n/a | ₹4b |
Mar 31 2020 | ₹66m | ₹66m | ₹4b |
Dec 31 2019 | n/a | n/a | ₹4b |
Sep 30 2019 | n/a | n/a | ₹4b |
Jun 30 2019 | n/a | n/a | ₹3b |
Mar 31 2019 | ₹90m | ₹47m | ₹3b |
Dec 31 2018 | n/a | n/a | ₹3b |
Sep 30 2018 | n/a | n/a | ₹3b |
Jun 30 2018 | n/a | n/a | ₹3b |
Mar 31 2018 | ₹94m | ₹47m | ₹3b |
Compensación vs. Mercado: La compensación total de Jonathan($USD1.02M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD539.67K).
Compensación vs. Ingresos: La compensación de Jonathan ha sido consistente con los resultados de la empresa en el último año.
CEO
Jonathan Hunt (54 yo)
8.3yrs
Permanencia
₹84,750,000
Compensación
Mr. Jonathan Brittan Hunt serves as the Managing Director of Syngene International Limited since April 1, 2020. He has been the Chief Executive Officer of Syngene International Ltd. since January 2016 and...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
MD, CEO & Executive Director | 8.3yrs | ₹84.75m | 0.087% ₹ 239.7m | |
CFO & Executive Director | 4.4yrs | ₹34.14m | 0.017% ₹ 46.9m | |
Head of Investor Relations | no data | sin datos | 0.0013% ₹ 3.6m | |
Company Secretary & Compliance Officer | 4.8yrs | ₹4.72m | 0.0031% ₹ 8.6m | |
Head of Corporate Communications | no data | sin datos | sin datos | |
Chief Human Resources Officer | 1.4yrs | sin datos | sin datos | |
Head of Pharmaceutical & Biopharmaceutical Development | no data | ₹10.80m | sin datos | |
Head of Formulations Development | no data | ₹5.50m | 0.029% ₹ 80.1m | |
Head of IT | 8.3yrs | sin datos | 0.00038% ₹ 1.0m | |
Head of Discovery Biology | 8.3yrs | sin datos | 0.0060% ₹ 16.5m | |
Head of Clinical Development & Stability Studies | 8.3yrs | sin datos | 0.0048% ₹ 13.2m | |
Head of EHSS | 6.3yrs | sin datos | 0.0063% ₹ 17.4m |
7.3yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de SYNGENE es experimentado (7.2 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
MD, CEO & Executive Director | 7yrs | ₹84.75m | 0.087% ₹ 239.7m | |
CFO & Executive Director | less than a year | ₹34.14m | 0.017% ₹ 46.9m | |
Non-Executive Director | 23.8yrs | ₹7.25m | 0.0022% ₹ 6.1m | |
Non-Executive Chairperson | no data | ₹8.23m | 0.0055% ₹ 15.1m | |
Lead Independent Director | 6.8yrs | ₹7.57m | sin datos | |
Independent Director | 7.2yrs | ₹6.93m | 0.013% ₹ 34.5m | |
Additional Independent Director | less than a year | sin datos | sin datos | |
Independent Non Executive Director | 2.9yrs | ₹5.61m | sin datos | |
Non-Executive Independent Director | 9.8yrs | ₹7.91m | 0.013% ₹ 34.5m | |
Additional Independent Director | 4.8yrs | ₹7.57m | sin datos |
6.8yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: La junta directiva de SYNGENE se considera experimentada (6.8 años de antigüedad promedio).